Cover Image
市場調查報告書

癌症骨轉移:全球臨床實驗趨勢

Bone Metastasis Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 217238
出版日期 內容資訊 英文 179 Pages
訂單完成後即時交付
價格
Back to Top
癌症骨轉移:全球臨床實驗趨勢 Bone Metastasis Global Clinical Trials Review, H1, 2015
出版日期: 2015年02月18日 內容資訊: 英文 179 Pages
簡介

本報告提供全球癌症骨轉移治療藥的臨床試驗情形之調查,依各階段,各進展狀況闡明主要國家的癌症骨轉移相關臨床實驗數量,主要企業·機關的簡介等。

簡介

  • 癌症骨轉移
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要5國的臨床實驗數量
    • 中南美主要5國的臨床實驗數量

G7各國臨床實驗數量:腫瘤相關臨床實驗上癌症骨轉移的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:腫瘤相關臨床實驗上癌症骨轉移的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標的達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

癌症骨轉移治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • Amgen Inc.
    • F. Hoffmann-La Roche Ltd.
    • Bayer AG
    • AstraZeneca PLC
    • Merck & Co., Inc.
    • Pfizer Inc.
    • AbbVie Inc.
    • Galil Medical Ltd.
    • Exelixis, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • University of Texas M. D. Anderson Cancer Center
    • University Health Network
    • National Cancer Institute
    • SWOG
    • West China Hospital
    • Washington University School of Medicine
    • Massachusetts General Hospital
    • Radiation Therapy Oncology Group
    • Sun Yat-sen University
    • Memorial Sloan Kettering Cancer Center

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2565CTIDB

GlobalData's clinical trial report, "Bone Metastasis Global Clinical Trials Review, H1, 2015" provides data on the Bone Metastasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bone Metastasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bone Metastasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Bone Metastasis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Bone Metastasis to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Bone Metastasis to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Bone Metastasis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Bone Metastasis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
      • Galil Medical Ltd.
      • Clinical Trial Overview of Galil Medical Ltd.
      • Exelixis, Inc.
      • Clinical Trial Overview of Exelixis, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center
      • University Health Network
      • Clinical Trial Overview of University Health Network
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • SWOG
      • Clinical Trial Overview of SWOG
      • West China Hospital
      • Clinical Trial Overview of West China Hospital
      • Washington University School of Medicine
      • Clinical Trial Overview of Washington University School of Medicine
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • Radiation Therapy Oncology Group
      • Clinical Trial Overview of Radiation Therapy Oncology Group
      • Sun Yat-sen University
      • Clinical Trial Overview of Sun Yat-sen University
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Bone Metastasis Therapeutics, Global, Clinical Trials by Region, 2015*
  • Bone Metastasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Bone Metastasis to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Bone Metastasis to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Bone Metastasis Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Bone Metastasis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Bone Metastasis Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Bone Metastasis Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Bone Metastasis Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Bone Metastasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Galil Medical Ltd., 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Exelixis, Inc., 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by SWOG, 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by West China Hospital, 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015*
  • Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015*

List of Figures

  • Bone Metastasis Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Bone Metastasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Bone Metastasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Bone Metastasis to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Bone Metastasis to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Bone Metastasis Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Bone Metastasis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Bone Metastasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Bone Metastasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top